Titan Medical - TMDI Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.66
▼ -0.03 (-4.34%)

This chart shows the closing price for TMDI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Titan Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TMDI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TMDI

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Titan Medical in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.66.

This chart shows the closing price for TMDI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 1 investment analysts is to hold stock in Titan Medical. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/18/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/16/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/15/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/15/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/13/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/11/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/10/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/10/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/25/2022OppenheimerDowngradeOutperform ➝ Market PerformMedium
11/15/2021Bloom BurtonDowngradeBuy ➝ AccumulateHigh
4/19/2021Bloom BurtonReiterated RatingBuyHigh
4/6/2021OppenheimerInitiated CoverageOutperform$4.00High
4/2/2020Maxim GroupReiterated RatingHoldHigh
4/1/2020Piper SandlerLower Target$1.50 ➝ $1.00Medium
12/23/2019Piper Jaffray CompaniesReiterated RatingBuy$2.50 ➝ $1.50Medium
11/18/2019Piper Jaffray CompaniesReiterated RatingBuy$2.50High
10/16/2019Maxim GroupDowngradeBuy ➝ HoldHigh
7/18/2019Northland SecuritiesReiterated RatingBuyLow
5/22/2019Piper Jaffray CompaniesInitiated CoverageOverweight$6.00 ➝ $6.00High
2/14/2019Maxim GroupReiterated RatingBuy$8.00High
1/3/2019Northland SecuritiesReiterated RatingBuy$6.00High
9/18/2018Northland SecuritiesInitiated CoverageOutperform$6.00High
9/17/2018Northland SecuritiesInitiated CoverageOutperform$6.00High
8/14/2018Maxim GroupLower TargetBuy ➝ Buy$11.00 ➝ $8.00High
6/28/2018Maxim GroupInitiated CoverageBuy$11.00High
(Data available from 12/10/2017 forward)

News Sentiment Rating

0.56 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/13/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/12/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/12/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/11/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/10/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/10/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/9/2022
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
12/9/2022

Current Sentiment

  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Titan Medical logo
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.
Read More

Today's Range

Now: $0.66
Low: $0.64
High: $0.68

50 Day Range

MA: $0.47
Low: $0.39
High: $0.84

52 Week Range

Now: $0.66
Low: $0.38
High: $0.93

Volume

193,050 shs

Average Volume

254,447 shs

Market Capitalization

$73.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.33

Frequently Asked Questions

What sell-side analysts currently cover shares of Titan Medical?

The following sell-side analysts have issued stock ratings on Titan Medical in the last twelve months: Oppenheimer Holdings Inc..
View the latest analyst ratings for TMDI.

What is the current price target for Titan Medical?

0 Wall Street analysts have set twelve-month price targets for Titan Medical in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Titan Medical in the next year.
View the latest price targets for TMDI.

What is the current consensus analyst rating for Titan Medical?

Titan Medical currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TMDI, but not buy more shares or sell existing shares.
View the latest ratings for TMDI.

What other companies compete with Titan Medical?

How do I contact Titan Medical's investor relations team?

Titan Medical's physical mailing address is 155 UNIVERSITY AVENUE, TORONTO A6, M5H 3B7. The company's listed phone number is (416) 548-7522. The official website for Titan Medical is www.titanmedicalinc.com. Learn More about contacing Titan Medical investor relations.